Cubist Systematic Strategies, LLC Neogenomics Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $167,009 - $202,439	-12,837 Reduced 10.97%	104,195 $1.45 Million
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $1.65 Million - $1.96 Million	117,032 New	117,032 $1.84 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $1.2 Million - $1.76 Million	98,551 Added 16846.32%	99,136 $1.22 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $8,248 - $11,600	585 New	585 $9,000
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $35,397 - $66,240	-5,488 Reduced 5.65%	91,672 $847,000
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $3.13 Million - $5.14 Million	-398,077 Reduced 80.38%	97,160 $837,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $2.37 Million - $4.68 Million	335,283 Added 209.61%	495,237 $4.04 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $1.61 Million - $4.66 Million	132,140 Added 475.08%	159,954 $1.94 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $848,048 - $1.35 Million	27,814 New	27,814 $949,000
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $797,164 - $1 Million	-19,135 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $213,457 - $301,301	5,829 Added 43.81%	19,135 $864,000
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $325,207 - $468,561	7,825 Added 142.77%	13,306 $642,000
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $2.51 Million - $3.94 Million	-69,705 Reduced 92.71%	5,481 $295,000
Q3 2020 Nov 16, 2020	BUY	$33.26 - $40.48 $2.5 Million - $3.04 Million	75,186 New	75,186 $2.77 Million
Q1 2020 May 15, 2020	SELL	$20.5 - $34.53 $270,374 - $455,416	-13,189 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $1.65 Million - $2.6 Million	-87,089 Reduced 86.85%	13,189 $386,000
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $579,699 - $795,570	-30,319 Reduced 23.22%	100,278 $1.92 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $2 Million - $2.46 Million	102,105 Added 358.36%	130,597 $2.87 Million
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $1.2 Million - $2.02 Million	-98,636 Reduced 77.59%	28,492 $583,000
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $1.4 Million - $2.31 Million	124,881 Added 5557.68%	127,128 $1.6 Million
Q3 2018 Nov 14, 2018	SELL	$12.5 - $15.38 $134,687 - $165,719	-10,775 Reduced 82.74%	2,247 $34,000
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $104,045 - $182,959	13,022 New	13,022 $171,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$333 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$238 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$117 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$112 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$111 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account